Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%

Seenu M Hariprasad1 Department of Ophthalmology and Visual Sciences, Vitreoretinal ServiceCorrespondence[email protected]

Levent Akduman2 Vitreoretinal Service, Saint Louis University Eye Institute, Saint Louis, MO, USA

Joseph A Clever2 Vitreoretinal Service, Saint Louis University Eye Institute, Saint Louis, MO, USA

Michael Ober3 Vitreoretinal Service, Henry Ford Health Systems, West Bloomfield, MI, USA;4 Retinal Consultants of Michigan, Southfield, MI, USA

Franco M Recchia5 Vitreoretinal Service, Vanderbilt Eye Institute, Nashville, TN, USA

William F Mieler1 Department of Ophthalmology and Visual Sciences, Vitreoretinal Service;6 Department of Ophthalmology and Visual Sciences, University of Chicago, Chicago, IL, USA

Pages 147-154 | Published online: 20 Jan 2009

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SolomonLDEfficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group IJ Cataract Refract Surg19952173817722910
PubMed Web of Science ®Google Scholar
UrsellPGSpaltonDJWhitcupSMNussenblattRBCystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuityJ Cataract Refract Surg1999251492149710569164
PubMed Web of Science ®Google Scholar
RaySD’AmicoDJPseudophakic cystoid macular edemaSemin Ophthalmol20021716718012759847
PubMedGoogle Scholar
WolfEJBraunsteinAShihCBraunsteinREIncidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenacJ Cataract Refract Surg2007331546154917720068
PubMed Web of Science ®Google Scholar
PrietoJFDiosEGutierrezJMPars planitis: epidemiology, treatment, and association with multiple sclerosisOcul Immunol Inflamm200199310211449325
PubMed Web of Science ®Google Scholar
GulkilikGKocaboraSTaskapiliMEnginGCystoid macular edema after phacoemulsification: risk factors and effect on visual acuityCan J Ophthalmol20064169970317224950
PubMed Web of Science ®Google Scholar
MiyakeKIbarakiNProstaglandins and cystoid macular edemaSurv Ophthalmol200247Suppl 1S203S21812204717
PubMed Web of Science ®Google Scholar
FlachAJThe incidence, pathogenesis and treatment of cystoid macular edema following cataract surgeryTrans Am Ophthalmol Soc19989655763410360304
PubMedGoogle Scholar
BazanNGde AbreuMTBazanHEBelfortRJrArachidonic acid cascade and platelet-activating factor in the network of eye inflammatory mediators: therapeutic implications in uveitisInt Ophthalmol1990143353442123479
PubMed Web of Science ®Google Scholar
HeierJSToppingTMBaumannWKetorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edemaOphthalmology200010720342038discussion, 2039.11054327
PubMed Web of Science ®Google Scholar
GilliesMCSutterFKSimpsonJMIntravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trialOphthalmology20061131533153816828501
PubMed Web of Science ®Google Scholar
ChoiJYBuzneySMWeiterJJCystoid macular edema: current modes of therapyInt Ophthalmol Clin20054514315116199973
PubMedGoogle Scholar
SivaprasadSMcCluskeyPLightmanSIntravitreal steroids in the management of macular oedemaActa Ophthalmol Scand20068472273317083528
PubMedGoogle Scholar
BucherRSHallEReedDMEffect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatmentArch Ophthalmol200512364965315883284
PubMedGoogle Scholar
FlachAJStegmanRCGrahamJKrugerLPProphylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked studyOphthalmology199097125312582243674
PubMed Web of Science ®Google Scholar
Italian Diclofenac Study GroupEfficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edemaJ Cataract Refract Surg199723118311899368162
PubMed Web of Science ®Google Scholar
FlachAJDolanBJIrvineAREffectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edemaAm J Ophthalmol19871034794863551617
PubMed Web of Science ®Google Scholar
FlachAJJampolLMWeinbergDImprovement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamineAm J Ophthalmol19911125145191951587
PubMed Web of Science ®Google Scholar
RhoDSTreatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolacJ Cataract Refract Surg2003292378238414709300
PubMed Web of Science ®Google Scholar
McColginAZRaizmanMBEfficacy of topical Voltaren in reducing the incidence of postoperative cystoid macular edemaInvest Ophthalmol Vis Sci199940SupplS289
Google Scholar
O’BrienTPEmerging guidelines for use of NSAID therapy to optimize cataract surgery patient careCurr Med Res Opin20052111311137Erratum in: Curr Med Res Opin. 2005;21:1431–2.16004683
PubMed Web of Science ®Google Scholar
GamacheDAGraffGBradyMTNepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacyInflammation20002435737010850857
PubMed Web of Science ®Google Scholar
HariprasadSMCallananDGaineySCystoid and diabetic macular edema treated with nepafenac 0.1%J Ocul Pharmacol Ther20072358559018001248
PubMed Web of Science ®Google Scholar
HariprasadSMCallananDTopical nepafenac 0.1% for treatment of chronic uveitic cystoid macular edemaRetin Cases Brief Rep20082304308
PubMedGoogle Scholar
WarrenKAFoxJETopical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patientsRetina2008281427143418664937
PubMed Web of Science ®Google Scholar
CallananDWilliamsPTopical nepafenac in the treatment of diabetic macular edemaClin Opthalmol200829991002
Google Scholar
KeTLGraffGSpellmanJMYanniJMNepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriersInflammation20002437138410850858
PubMed Web of Science ®Google Scholar
KapinMAYanniJMBradyMTInflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenacInflammation20032728129114635785
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date